EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii

Elijah Kolawole Oladipo, Stephen Feranmi Adeyemo, Glory Jesudara Oluwasanya, Esther Oluwadarasimi Adaramola, Shalom Busayo Akintola, Victor Oluwatobi Afolabi, Joel Damilare Ajagbe, Oluwadara Hannah Ojo, Emmanuel Pelumi Kolapo, Emmanuel Owoeye, Esther Moradeyo Jimah, Ademola O Ayeleso und 1 weitere

Microbial Pathogenesis · 2025

DOI: 10.1016/j.micpath.2025.107361 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Elijah Kolawole Oladipo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacotherapies Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria; Division of Vaccine Design and Developmen…. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Acinetobacter Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialAcinetobacter InfectionsHumansAntimicrobial PeptidesNanoparticlesDrug Therapy, CombinationPhage Therapy

Stichwörter der Autor:innen

Acinetobacter baumanniiAntibacterial agentsAntimicrobial peptidesCombination therapiesMultidrug resistance (MDR)Nanoparticle-based therapies

Substanzen

Anti-Bacterial AgentsAntimicrobial Peptides

Autor:innen und Institutionen

  • Division of Pharmacotherapies Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria; Department of…
  • Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria. Electronic address: stephenf.adeyemo@gmail.com.
  • Division of Pharmacotherapies Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.
  • Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.
  • Division of Pharmacotherapies Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria; Department of Pure and Applied Biology, Ladoke Akintola University of Technology, Ogbomoso, Oyo state, Nigeria.
  • Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.

Zitieren

APA

Oladipo, E. K., Adeyemo, S. F., Oluwasanya, G. J., Adaramola, E. O., Akintola, S. B., Afolabi, V. O., Ajagbe, J. D., Ojo, O. H., Kolapo, E. P., Owoeye, E., Jimah, E. M., Ayeleso, A. O., & Onyeaka, H. (2025). Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107361

Vancouver

Oladipo EK, Adeyemo SF, Oluwasanya GJ, Adaramola EO, Akintola SB, Afolabi VO, et al. Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107361

BibTeX
@article{Oladipo2025,
  author = {Oladipo, Elijah Kolawole and Adeyemo, Stephen Feranmi and Oluwasanya, Glory Jesudara and Adaramola, Esther Oluwadarasimi and Akintola, Shalom Busayo and Afolabi, Victor Oluwatobi and Ajagbe, Joel Damilare and Ojo, Oluwadara Hannah and Kolapo, Emmanuel Pelumi and Owoeye, Emmanuel and Jimah, Esther Moradeyo and Ayeleso, Ademola O and Onyeaka, Helen},
  title = {Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii},
  journal = {Microbial Pathogenesis},
  year = {2025},
  doi = {10.1016/j.micpath.2025.107361}
}
Kostenlos starten →